Differences in the Induction of Induced Human CD4+ CD25+ FoxP3+ T-Regulatory Cells and CD3+ CD8+ CD28??? T-Suppressor Cells Subset Phenotypes In Vitro: Comparison of Phorbol 12-Myristate 13-Acetate/Ionomycin and Phytohemagglutinin Stimulation, Transplantation Proceedings, vol.45, issue.5, pp.1822-1831, 2013. ,
DOI : 10.1016/j.transproceed.2012.10.061
Detection of intracellular cytokines by flow cytometry, Curr Protoc Immunol, issue.6, 2007. ,
Biomarkers as a Tool for Management of Immunosuppression in Transplant Patients, Therapeutic Drug Monitoring, vol.32, issue.5, pp.560-572, 2010. ,
DOI : 10.1097/FTD.0b013e3181efb3d2
Tacrolimus Pharmacodynamics and Pharmacogenetics along the Calcineurin Pathway in Human Lymphocytes, Clinical Chemistry, vol.60, issue.10, pp.1336-1345, 2014. ,
DOI : 10.1373/clinchem.2014.223511
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols, Leukemia, vol.70, issue.9, pp.1986-2010, 2012. ,
DOI : 10.1002/cyto.b.20135
URL : https://hal.archives-ouvertes.fr/hal-00739978
A model for harmonizing flow cytometry in clinical trials, Nature Immunology, vol.73, issue.11, pp.975-978, 2010. ,
DOI : 10.1016/j.immuni.2009.09.007
Validation of cell-based fluorescence assays: practice guidelines from the ICSH and ICCS - part II - preanalytical issues, Cytometry Part B: Clinical Cytometry, vol.275, issue.Suppl 1, pp.286-290, 2013. ,
DOI : 10.1016/S0022-1759(03)00009-7
Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - part V - assay performance criteria, Cytometry Part B: Clinical Cytometry, vol.9, issue.5, pp.315-323, 2013. ,
DOI : 10.1208/aapsj0902013